Xeris Biopharma Holdings, Inc. XERS Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s deferred tax assets and other non-current assets?
- Xeris Biopharma Holdings, Inc. (XERS) reported deferred tax assets and other non-current assets of $5.12M in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s deferred tax assets and other non-current assets increased by 0.5% year-over-year, from $5.1M to $5.12M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s deferred tax assets and other non-current assets has grown at a 86.4% compound annual growth rate (CAGR), from $232K to $5.22M.